Physician profile
Nir Shimony
NPI 1730625450
$7,452.84
in general payments reported to CMS, 2019-2025
9 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,795 · 2022: $226 · 2023: $571 · 2024: $2,635 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,889 · Food and Beverage: $1,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,888.79 |
| Food and Beverage | $1,542.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $3,306.93 | 2019 | |
| Medtronic, INC. | $1,516.28 | 2024-2025 | Stealthstation S8 Platform, Percept Pc Brainsense |
| Neuropace, INC. | $1,460.82 | 2022-2025 | |
| Aesculap Akademie Gmbh | $399.32 | 2019 | |
| Kls-Martin L.P. | $272.08 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $186.43 | 2024 | Rosa |
| Monteris Medical Corporation | $114.64 | 2024 | Neuroblate |
| Jazz Pharmaceuticals INC. | $107.67 | 2022 | |
| Brainlab, INC. | $88.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nir Shimony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.